Early rehabilitation is recommended in many guidelines, with limited evidence to guide practice. Brain neurobiology suggests that early training, at the right dose, will aid recovery. In this review, we highlight recent trials of early mobilization, aphasia, dysphagia and upper limb treatment in which intervention is commenced within 7 days of stroke and discuss future research directions.
INTRODUCTION
Early commencement of rehabilitation after stroke is recommended in many clinical practice guidelines [1 & ]. Recommendations are typically general in nature. Rarely are the specific timing, dose or content of rehabilitation interventions defined, which reflects the current evidence base. In principal, there are few good reasons to delay rehabilitation. But to progress the field, we need better understanding of what interventions can or should be started early, in what dose and using what schedule to optimize patient recovery. In this review, we define 'early rehabilitation' as interventions directed at improving poststroke impairments or disability that commence within the first 7 days after stroke. We chose the first 7 days for several reasons. With average length of acute hospital stay in many Western countries around 7 days, for many this period represents first (and for many patients only) access to multidisciplinary treatment in an organized stroke service. Around a third of stroke patients go on to receive some inpatient rehabilitation, although in lower income countries, postacute stroke rehabilitation services are rare or nonexistent.
Second, recognizing that understanding the neural substrates of recovery will help us develop better treatments underpinned by biology [2 & ], preclinical research suggests that there is an early 'critical' or 'sensitive' period in which the brain is most responsive to improvements induced by motor training [3] , with the first days and weeks important [4 Taken together, applying targeted treatments within an early sensitive period in a stimulating environment should provide the best opportunity of achieving true neurological recovery after stroke [3,4 & ] .
In this review, we highlight recent early intervention trials in mobility and exercise training, speech and language, swallowing and upper limb training. We searched PubMed for full journal articles and searched the Cochrane Stroke Group trials register for trials published since 2015 in any of the areas outlined above. We excluded pharmaceutical trials.
EARLY MOBILITY TRAINING, MOBILIZATION AND EXERCISE
Although the international, multicenter AVERT trial dominates the trial landscape, interest in early onset mobility training and mobilization has resulted in publication of a number of new randomized controlled trials (Table 1) since our 2015 review [1 & ] of the field. In the multicenter SEVEL trial [6 & ], an early sitting protocol, initiated within 1 calendar day after stroke onset, was compared with a late protocol commenced at day 3 for patients with ischemic stroke. Only the timing of first intervention was recorded, not subsequent interventions throughout hospitalization. Primary outcome was modified Rankin Scale (mRS) at 3 months after stroke, with medical complications as key secondary outcomes. Patients were recruited from 11 French stroke centers, and planned sample size was 366 patients. Unfortunately, slow recruitment (largely due to poor trial infrastructure) led investigators to close the trial early (total sample n ¼ 167; early sitting n ¼ 82 and later n ¼ 85). There were no significant differences in mRS or complications at 3 months. Complication rates were low overall, and both interventions were well tolerated. A Brazilian study by Poletto et al. [7 & ] aimed to test the safety and feasibility of a protocol commencing within 48 h of stroke onset incorporating sitting out of bed and 30 min of functional training per day led by a physiotherapist, 5 days a week compared with usual care (physical therapy generally performed in bed and only conducted when requested by staff). Planned recruitment was for 174 patients (82 per group), with mRS the primary outcome at 3 months after stroke, and feasibility and safety endpoints that included the timing and duration of physical therapy. Once again, slow recruitment led investigators to close the study early, with late hospital arrival (>48 h after stroke) cited as the primary reason for the high exclusion rate. Only 37 participants completed the trial (n ¼ 18 early and n ¼ 19 usual care). Although the intervention was feasible with no safety concerns noted, there were no significant differences in any of the outcomes.
Two further randomized controlled trials from India [8] and Italy [9 & ] have also been reported in the last 12 months. Chippala and Sharma [8] largely adopted the phase II AVERT protocol [15] , randomizing patients to mobilization out of bed within 24 h of stroke onset (n ¼ 43), with 5-30 min of upright activities (as tolerated) per day or to usual care (n ¼ 43). The Barthel Index was used to assess functional status at 3 months with the authors reporting significantly greater independence in the intervention group at 3 months compared with patients who received lower dose usual care. The investigators in the Italian trial [9 & ] tested early versus delayed application of two different approaches to rehabilitation. Using a factorial design they compared early proprioceptive neuromuscular facilitation (PNF) or cognitive therapeutic exercise (CTE) commenced within 24 h of admission, with delayed PNF and CTE groups, where treatment started 4 days later. A total of 340 patients were randomized, and followup occurred at 3 and 12 months. All groups improved over time, with no significant differences in mRS or Barthel Index between the early and delayed groups or between treatment approaches at 3 months.
Interventions tested in these trials ranged from simple out-of-bed sitting protocols, to more targeted, higher dose training. Many test the feasibility of delivering higher dose interventions within their stroke settings. A recent exercise study investigating the feasibility of 'intensive' treadmill training within 2 days of onset of stroke symptoms, though small (n ¼ 25), is worth noting [11] . Rarely is cardiovascular fitness a training target in the early time window. Thirty minutes of treadmill training, with bodyweight support as needed, twice daily for 5
KEY POINTS
An early sensitive or critical period for recovery is likely in humans; we need to develop rehabilitation treatments that harness potential for recovery.
Interest in early mobility training and mobilization evidenced by a flurry of new trials in the first days after stroke.
Challenges of conducting trials of early rehabilitation interventions are highlighted in this review.
Several large early aphasia trials will be reporting in the next 18 months.
Early rehabilitation after stroke Bernhardt et al. To briefly recap, AVERT compared a frequent, higher dose of out-of-bed mobility based training protocol (on top of usual care) started within 24 h of stroke onset and continued for 14 days or until discharge, to usual care alone. Primary outcome was mRS at 3 months. We found that the higher dose protocol resulted in lower odds of a favorable outcome at 3 months (mRS 0-2) compared with usual care, which also started at a median time of 22.4 h after stroke. This finding surprised many. Importantly, our results call into question the common therapeutic axiom that 'more is better', particularly in the very early time window after stroke [3,10 & ,19] . Further, our results highlight our need to better understand the biology of recovery and human response to training in the early poststroke period when the critical period is believed to exist. Our exploratory subgroup analyses of the primary outcome [10 & ] found no significant treatment-bysubgroup interactions, although patients with severe stroke (NIHSS > 16, n ¼ 291) and those with intracerebral haemorrhage (n ¼ 255) showed less favorable outcomes when treated with the higher intensity regimen. Interestingly, those treated with intravenous rtPA (n ¼ 503) were no different in their response to treatment. Although further prespecified analyses are ongoing, particularly around safety, later outcomes and cost [16 & ,20 & ], our dose-response analysis results suggest that although higher amounts of training have a deleterious effect on outcome (mRS at 3 months, walking recovery, and death), higher frequency of intervention is associated with more favorable outcome [17 & ]. These findings provide a new direction for future studies, suggesting that both training thresholds and scheduling may be important in the very early period [19] . Whether we should avoid any activity in the first day(s) after stroke is currently unknown. The favorable outcome and low complication rates experienced by patients in the usual care group in AVERT who also started some activity out of bed early suggests that a ban on out-of-bed activity is unwarranted. The current HeadPoST [21 & ] cluster trial in which patients spend 24 h after admission flat may provide further insights to guide practice.
THROMBOLYSIS AND EARLY MOBILIZATION
We included patients treated with rtPA (alteplase) in AVERT; it is standard of care, and protocols restricting patients to bed for 24 h are not evidence-based. Recently, a detailed observational study (n ¼ 18) by Arnold et al. [22 & ] examined the safety profiles of ischemic stroke patients commencing out-of-bed mobilization and rehabilitation between 13 and 23 h after treatment with intravenous rtPA. No serious bleeding complications were found, although one patient experienced transient neurological changes with mobilization, which resolved with rest. No long-term outcomes were examined. At the other end of the spectrum, a recent large (n ¼ 6153) retrospective study of those treated with intravenous rtPA by Momosaki et al. [23] examined the association between starting rehabilitation (any physical or occupational therapy) within 3 days of admission and functional independence (mRS 0-2) at hospital discharge. Using a Japan-wide hospital database, and adjusting for age, sex, type of ischemic stroke, baseline mRS, comorbidities and process factors (admission day, unit size etc.), the authors found significantly higher levels of independence in those receiving early rehabilitation and no differences in mortality or the incidence of hemorrhage. It remains unclear if rapid mobilization or rehabilitation is desirable after rtPA treatment and whether successful recanalization following treatment has an important influence.
EARLY DYSPHAGIA AND APHASIA TREATMENT
Unlike early mobilization, which has seen a flurry of trial activity in the last 12 months, we found only one recent small trial of early dysphagia treatment with repetitive transcranial magnetic stimulation (rTMS) [24 & ]. In this 3-arm trial, 3 Hz (n ¼ 15), 1 Hz (n ¼ 13) and sham rTMS (n ¼ 12) was applied to patients recruited a median of 6-9 days from stroke onset over 5 consecutive days. The primary outcome, Standardised Swallowing Assessment (SSA), was assessed by a blinded neurologist at 3 months. The authors found a significant improvement in SSA in both treatment groups that was retained to 3 months, but no change in the sham rTMS group. No harms were reported. The longer follow-up period and retention of effect found here suggest that it may be time for larger trials of rTMS for dysphagia treatment.
We identified two protocols for trials of early aphasia interventions [13, 14] . The Rotterdam Aphasia Therapy Study-3 [14] compares communication outcomes in people with first-ever acute stroke (n ¼ 150) following early intensive cognitivelinguistic therapy starting before day 14 and those who received usual care aphasia therapy starting after day 30. This multicenter trial closed late in 2015, and results are under review. The very early rehabilitation in speech (VERSE) trial is ongoing with full recruitment (n ¼ 246) expected in 2017 [13] . The VERSE trial is testing whether two forms of daily, prescribed aphasia therapy for 20 sessions, beginning within 14 days of acute stroke, is more effective and cost saving than usual care at 3 months. Both trials begin aphasia intervention within the first week poststroke. Intervention continues into subacute recovery for 4 weeks, according to the ongoing therapeutic needs of stroke survivors. Exemplary collaboration between acute care, rehabilitation and community healthcare sites (and multiple ethics applications) is essential to achieve seamless clinical care and delivery of research outcomes. The challenge of interventions that span acute/rehabilitation/community care is a major barrier to early rehabilitation trials. The results of these trials are eagerly awaited.
EARLY UPPER LIMB REHABILITATION
In the EXPLICIT-Stroke program trials, recruitment occurred an average of 8 days after stroke [12 & ]. Two interventions were tested; for patients with a favorable prognosis, a modified 3-week constraint induced movement therapy (mCIMT) program (n ¼ 29) was compared with usual care (n ¼ 29), whereas those with unfavorable prognosis were allocated to a 3-week electromagnetic neuromuscular stimulation (EMG-NMS) program (n ¼ 50) or usual care (n ¼ 51). The primary outcome for both trials was the Action Research Arm Test (ARAT) score with final follow-up at 26 weeks. The mCIMT program was more effective at improving function than usual care early, but effects were not sustained at 26 weeks. There was no benefit of EMG-NMS in those with poorer prognosis over usual care. Nested imaging and transcranial magnetic simulation studies to examine brain recovery characteristics in 30 patients from each of the prognostic groups are planned [25] .
In this review, we have identified some of the challenges of rehabilitation research in the early time window. Rehabilitation trials are complex, often requiring input from multidisciplinary teams. Standardized, early recruitment is vital to improving the quality of our trials. How we stratify and select patients in recovery trials is not a trivial question. If we consider the benefits to be gained from careful, imaging-based selection in many acute stroke trials, it is clear that we need to strive for more sophisticated approaches to patient selection. One example of an approach to determine the recovery potential of the upper limb based on remaining neurobiological characteristics is the PREP algorithm [26] . An important distinction of this approach is that it is step-down, pulling in brain imaging techniques (e.g. transcranial magnetic stimulation and MRI) only when they have the potential to add information over and above what can be derived from clinical outcome measures. This approach has the potential to improve patient selection for upper limb intervention trials and be extended to other domains. At present however, our understanding of who recovers, who doesn't and why in response to treatment is incomplete and remains a priority.
CONCLUSION
Rehabilitation research has come a long way in recent years, but still has a long way to go. This year, the first Stroke Recovery and Rehabilitation Roundtable was held with 60 world stroke experts. Our goal was to develop recommendations for standardization and improved research practice in key areas -preclinical research, biomarkers, clinical trial outcomes and intervention development and monitoring [2 & ]. Recommendations will be available early 2017. An important discussion point at the meeting was the need to start interventions earlier (during the critical window) and to apply them at the right dose to improve the potential for neurological recovery and repair. It is exciting to see the benefit of new intra-arterial treatments, which improve not just global disability (mRS), but aphasia and other motor outcomes [27] . Like acute stroke, we need to discover a game-changing treatment(s) that improves the potential for true recovery in the thousands of stroke survivors battling disability each year. Breakthrough interventions are likely to be multimodal [3, 4 & ]. Such a discovery would kick start the next series of focused studies that will change the recovery landscape forever.
